U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
190831190831Treatment of Medically Unexplained Physical Ailments (Somatization Disorder)CompletedNo Results AvailableSomatoform DisordersBehavioral: Cognitive Behavioral Therapy|Behavioral: CBThttps://ClinicalTrials.gov/show/NCT00050583
190832190832Reducing Eating Disorder Risk FactorsCompletedNo Results AvailableEating DisordersBehavioral: Web-based intervention to reduce eating disorder risk factorshttps://ClinicalTrials.gov/show/NCT00050570
190833190833Family Psychoeducation for Children With Mood DisordersCompletedNo Results AvailableMood DisordersBehavioral: Multifamily Psychoeducation Group (MFPG)|Behavioral: Treatment as usual (TAU)https://ClinicalTrials.gov/show/NCT00050557
190834190834High-Dose Gleevec Alone or in Combination With Peg-Intron and GM-CSF in Early Phase Chronic Myelogenous Leukemia (CML)CompletedNo Results AvailableLeukemia, Myeloid, ChronicDrug: Gleevec|Drug: Peg-alpha interferon (Peg-Intron)|Drug: Sargramostim (GM-CSF)https://ClinicalTrials.gov/show/NCT00050531
190835190835APSV in Vaccinia Naive AdultsCompletedNo Results AvailableSmallpoxBiological: Aventis Pasteur Smallpox Vaccinehttps://ClinicalTrials.gov/show/NCT00050518
190836190836Expanded Dryvax Dilution Study in Previously Vaccinated AdultsCompletedNo Results AvailableSmallpoxBiological: Live vaccinia virus vaccine|Biological: Live vaccinia virus vaccinehttps://ClinicalTrials.gov/show/NCT00050505
190837190837Biological Markers in Retinal VasculitisCompletedNo Results AvailableRetinal Vasculitishttps://ClinicalTrials.gov/show/NCT00050492
190838190838Laser and Medical Treatment of Diabetic Macular EdemaCompletedNo Results AvailableMacular DegenerationDrug: Celecoxib (Celebrex)https://ClinicalTrials.gov/show/NCT00050479
190839190839Dynamic Light Scattering and Keratoscopy for Corneal ExaminationCompletedNo Results AvailableCorneal Diseaseshttps://ClinicalTrials.gov/show/NCT00050466
190840190840Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial CarcinomaCompletedNo Results AvailableEndometrial Neoplasms|Uterine Neoplasms|Genital Neoplasms, Female Urogenital NeoplasmsDrug: Trabectedin|Drug: Dexamethasonehttps://ClinicalTrials.gov/show/NCT00050440
190841190841A Study of ET-743 (Trabectedin) in Patients With Advanced Breast CancerCompletedNo Results AvailableBreast Neoplasms|Neoplasms|Neoplasms by Site|Breast Diseases|Skin DiseasesDrug: ET743|Drug: ET743https://ClinicalTrials.gov/show/NCT00050427
190842190842A Study of Trabectedin in Patients With Advanced Ovarian CancerCompletedNo Results AvailableOvarian Neoplasms|Endocrine Gland Neoplasms|Neoplasms by Site|Neoplasms|Ovarian Diseases|Adnexal Diseases|Genital Diseases, FemaleDrug: Trabectedin|Drug: Dexamethasonehttps://ClinicalTrials.gov/show/NCT00050414
190843190843Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia Requiring Mechanical Ventilatory SupportCompletedNo Results AvailablePneumoniaDrug: MERREM I.V. 2g as a 3 hour infusion every 8 hours|Drug: vancomycin I.V. 1 g every 12 hours|Drug: tobramycin I.V. 5 mg/kg every 24 hours|Drug: MERREM I.V. 1g as a 30 minute infusion every 8 hours|Drug: MERREM I.V. 500 mg as a 3 hour infusion every 8 hourshttps://ClinicalTrials.gov/show/NCT00050401
190844190844Phase II Trial of Allovectin-7® for Head and Neck CancerCompletedNo Results AvailableHead and Neck Cancer|Squamous Cell Carcinoma of the Oral Cavity or Oropharynx|Head and Neck Neoplasms|Carcinoma of the Head and NeckGenetic: Allovectin-7®https://ClinicalTrials.gov/show/NCT00050388
190845190845Clinical Trial for Ovarian Cancer (OvaRex®)TerminatedNo Results AvailableOvarian CancerDrug: oregovomabhttps://ClinicalTrials.gov/show/NCT00050375
190846190846Rofecoxib and Bupivacaine to Prevent Pain After Third Molar (Wisdom Tooth) ExtractionCompletedNo Results AvailablePain|Tooth ExtractionDrug: Rofecoxib and Bupivacainehttps://ClinicalTrials.gov/show/NCT00050362
190847190847EPO906 in Carcinoid and Other Neuroendocrine TumorsCompletedNo Results AvailableCarcinoid|Neuroendocrine TumorsDrug: EPO906 epothilone Bhttps://ClinicalTrials.gov/show/NCT00050349
190848190848Study of Lonafarnib in Combination With Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer (Study P01901)(TERMINATED)TerminatedNo Results AvailableCarcinoma, Non-small-cell Lung|Metastases, NeoplasmDrug: Lonafarnib (SARASAR)https://ClinicalTrials.gov/show/NCT00050336
190849190849Safety/Efficacy of a Vaccine Prepared From Dendritic Cells Combined With Tumor Cells to Treat Advanced Kidney CancerCompletedNo Results AvailableCarcinoma, Renal CellDrug: Allogeneic DCs and Autologous RCC Tumor Derived Cellshttps://ClinicalTrials.gov/show/NCT00050323
190850190850Natural History of Anthrax: a Study of Primary Infected, Recovered, and Exposed Individuals (SPoRE); and Evaluation of AVA-Vaccinated RecipientsRecruitingNo Results AvailableAnthraxhttps://ClinicalTrials.gov/show/NCT00050310
190851190851YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate CancerTerminatedNo Results AvailableProstate CancerDrug: YM598https://ClinicalTrials.gov/show/NCT00050297
190852190852Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV InfectionCompletedNo Results AvailableHIV Infectionshttps://ClinicalTrials.gov/show/NCT00050284
190853190853Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral NeuropathyCompletedNo Results AvailableHIV Infections|Peripheral Nervous System DiseasesDrug: Acetyl-L-carnitinehttps://ClinicalTrials.gov/show/NCT00050271
190854190854Rituximab to Treat Neuropathy With Anti-MAG AntibodiesCompletedNo Results AvailablePolyneuropathiesDrug: Rituximabhttps://ClinicalTrials.gov/show/NCT00050245
190855190855Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis PatientsCompletedNo Results AvailableMultiple SclerosisDrug: AVP-923https://ClinicalTrials.gov/show/NCT00050232
190856190856Role of Dopamine in Response to AlcoholCompletedNo Results AvailableAlcohol Consumptionhttps://ClinicalTrials.gov/show/NCT00050219
190857190857Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I DisorderCompletedNo Results AvailableBipolar DisorderDrug: Olanzapine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00050206
190858190858Cause and Natural Course of Pediatric-Onset MastocytosisCompletedNo Results AvailableMastocytosishttps://ClinicalTrials.gov/show/NCT00050193
190859190859Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy VolunteersCompletedNo Results AvailableHealthy|HIV InfectionsDrug: Midazolam|Drug: Indinavir|Drug: Saquinavirhttps://ClinicalTrials.gov/show/NCT00050180
190860190860Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast CancerCompletedHas ResultsBreast CancerDrug: Paclitaxel|Drug: Docetaxel|Drug: Capecitabinehttps://ClinicalTrials.gov/show/NCT00050167

* Görseller ve İçerik tekif hakkına sahip olabilir